These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36448814)

  • 1. Utility of the Signal-to-Cutoff Ratio and Antigen Index from Fourth- and Fifth-Generation HIV-1/HIV-2 Antigen/Antibody Assays for the Diagnosis of Acute HIV Infection: Applicability for Real-Time Use for Immediate Initiation of Antiretroviral Therapy.
    Whitney E; Pitrak D; Beavis KG; Moore NM; Shankaran S; Abeleda AP; Schmitt J; Sha BE
    J Clin Microbiol; 2022 Dec; 60(12):e0120422. PubMed ID: 36448814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of an alternative HIV diagnostic algorithm using the ARCHITECT HIV Ag/Ab Combo assay and potential utility of sample-to-cutoff ratio to discriminate primary from established infection.
    Ramos EM; Harb S; Dragavon J; Swenson P; Stekler JD; Coombs RW
    J Clin Virol; 2013 Dec; 58 Suppl 1(0 1):e38-43. PubMed ID: 24029686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay.
    Chavez P; Wesolowski L; Patel P; Delaney K; Owen SM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S51-5. PubMed ID: 21983253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of fourth-generation ARCHITECT HIV Ag/Ab Combo assay and utility of signal-to-cutoff ratio to predict false-positive HIV tests in pregnancy.
    Adhikari EH; Macias D; Gaffney D; White S; Rogers VL; McIntire DD; Roberts SW
    Am J Obstet Gynecol; 2018 Oct; 219(4):408.e1-408.e9. PubMed ID: 29913173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance comparison of the 4th generation Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA on the EVOLIS™ automated system versus Abbott ARCHITECT HIV Ag/Ab Combo, Ortho Anti-HIV 1+2 EIA on Vitros ECi and Siemens HIV-1/O/2 enhanced on Advia Centaur.
    Mitchell EO; Stewart G; Bajzik O; Ferret M; Bentsen C; Shriver MK
    J Clin Virol; 2013 Dec; 58 Suppl 1():e79-84. PubMed ID: 24342482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased Seroreactivity in Individuals Initiating Antiretroviral Therapy during Acute HIV Infection.
    Manak MM; Jagodzinski LL; Shutt A; Malia JA; Leos M; Ouellette J; Akapirat S; Colby DL; Phanuphak N; Eller LA; Robb ML; de Souza M; Ananworanich J; Peel SA;
    J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31217270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the fourth-generation Bio-Rad GS HIV Combo Ag/Ab enzyme immunoassay for diagnosis of HIV infection in Southern Africa.
    Piwowar-Manning E; Fogel JM; Richardson P; Wolf S; Clarke W; Marzinke MA; Fiamma A; Donnell D; Kulich M; Mbwambo JK; Richter L; Gray G; Sweat M; Coates TJ; Eshleman SH
    J Clin Virol; 2015 Jan; 62():75-9. PubMed ID: 25542477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Architect HIV Ag/Ab Combo Assay in a low-prevalence setting: The role of samples with a low S/CO ratio.
    Alonso R; Pérez-García F; Gijón P; Collazos A; Bouza E
    J Clin Virol; 2018 Jun; 103():43-47. PubMed ID: 29635210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Optimal Cutoff Value to Predict HIV Infection Using the Architect HIV Ag/Ab Combo.
    Zhang X; Zhou X; He X; Liu X; Wang Z
    Clin Lab; 2022 Apr; 68(4):. PubMed ID: 35443578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Detection Limits of Fourth- and Fifth-Generation Combination HIV Antigen-Antibody, p24 Antigen, and Viral Load Assays on Diverse HIV Isolates.
    Stone M; Bainbridge J; Sanchez AM; Keating SM; Pappas A; Rountree W; Todd C; Bakkour S; Manak M; Peel SA; Coombs RW; Ramos EM; Shriver MK; Contestable P; Nair SV; Wilson DH; Stengelin M; Murphy G; Hewlett I; Denny TN; Busch MP
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29793968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of cutoff on a 4th generation ELISA performance in the false positive rate during HIV diagnostic in a low HIV prevalence setting.
    Chacón L; Mateos ML; Holguín Á
    J Clin Virol; 2017 Jul; 92():11-13. PubMed ID: 28501753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Application Evaluation of a Fourth-Generation HIV Antigen Antibody Combination Screening Assay.
    Han H; Huang Y; Dong Q; Huang Y; Lu J; Wang W; Chen K
    Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample-to-cutoff ratios using Architect HIV Ag/Ab Combo: The influence with the results of supplemental tests and optimal cutoff value to predict HIV infection.
    Wang L; Wang JY; Tian XD; Ruan JX; Yu Y; Yan F
    J Clin Lab Anal; 2019 Jun; 33(5):e22866. PubMed ID: 30803030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of early HIV infections using the fourth generation Abbott ARCHITECT HIV Ag/Ab Combo chemiluminescent microparticle immunoassay (CIA) in San Diego County.
    Manlutac AL; Giesick JS; McVay PA
    J Clin Virol; 2013 Dec; 58 Suppl 1():e44-7. PubMed ID: 24342477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance evaluation of three automated human immunodeficiency virus antigen-antibody combination immunoassays.
    Kwon JA; Yoon SY; Lee CK; Lim CS; Lee KN; Sung HJ; Brennan CA; Devare SG
    J Virol Methods; 2006 Apr; 133(1):20-6. PubMed ID: 16313975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterophilic interference in specimens yielding false-reactive results on the Abbott 4th generation ARCHITECT HIV Ag/Ab Combo assay.
    Lavoie S; Caswell D; Gill MJ; Kadkhoda K; Charlton CL; Levett PN; Hatchette T; Garceau R; Maregmen J; Mazzulli T; Needle R; Kadivar K; Kim J
    J Clin Virol; 2018 Jul; 104():23-28. PubMed ID: 29704735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 4th-Generation HIV Antigen/Antibody Combination Assay With 3rd-Generation HIV Antibody Assays for the Occurrence of False-Positive and False-Negative Results.
    Muthukumar A; Alatoom A; Burns S; Ashmore J; Kim A; Emerson B; Bannister E; Ansari MQ
    Lab Med; 2015; 46(2):84-9; quiz e28-9. PubMed ID: 25918186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor performance of the determine HIV-1/2 Ag/Ab combo fourth-generation rapid test for detection of acute infections in a National Household Survey in Swaziland.
    Duong YT; Mavengere Y; Patel H; Moore C; Manjengwa J; Sibandze D; Rasberry C; Mlambo C; Li Z; Emel L; Bock N; Moore J; Nkambule R; Justman J; Reed J; Bicego G; Ellenberger DL; Nkengasong JN; Parekh BS
    J Clin Microbiol; 2014 Oct; 52(10):3743-8. PubMed ID: 25122853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of the new HIV-1/2 diagnostic algorithm in Florida's public health testing population: a review of the first five months of utilization.
    Bennett B; Neumann D; Fordan S; Villaraza R; Crowe S; Gillis L
    J Clin Virol; 2013 Dec; 58 Suppl 1():e29-33. PubMed ID: 24342476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008.
    Patel P; Mackellar D; Simmons P; Uniyal A; Gallagher K; Bennett B; Sullivan TJ; Kowalski A; Parker MM; LaLota M; Kerndt P; Sullivan PS;
    Arch Intern Med; 2010 Jan; 170(1):66-74. PubMed ID: 20065201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.